Tidal Investments LLC increased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 348.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,123 shares of the company's stock after acquiring an additional 77,005 shares during the period. Tidal Investments LLC's holdings in HCA Healthcare were worth $29,752,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the 4th quarter worth $31,000. Tidemark LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $36,000. Activest Wealth Management raised its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares during the last quarter. Legacy Investment Solutions LLC raised its stake in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after buying an additional 95 shares during the last quarter. Finally, Physician Wealth Advisors Inc. purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $64,000. Hedge funds and other institutional investors own 62.73% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on HCA shares. Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Robert W. Baird reissued a "neutral" rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Finally, Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average price target of $381.13.
Read Our Latest Stock Report on HCA
HCA Healthcare Trading Down 0.9%
Shares of HCA stock traded down $3.62 during trading on Wednesday, hitting $382.43. 1,118,243 shares of the stock traded hands, compared to its average volume of 1,436,125. The firm has a market capitalization of $92.00 billion, a P/E ratio of 17.41, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm's fifty day moving average price is $343.61 and its 200-day moving average price is $328.91. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.36 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.